Answers are grounded in this paper and cite their sources.
This commentary suggests that lipid management in the elderly should potentially prioritize triglycerides and HDL-C over LDL-C, highlighting the need for dedicated intervention trials.
Coronary Heart Disease in the ElderlyResults from the Cardiovascular Health Study' underscore the need of well-designed intervention trials for the prevention of coronary heart disease in the elderly and raise the issue of which lipoproteins to target.Additionally, the study suggests that the National Cholesterol Education Program guidelines may not be applicable to the elderly.Analysis of this population-based epidemiological study in the elderly indicates that the levels of triglycerides and high density lipoprotein cholesterol (HDL-C) but not low density lipoprotein cholesterol (LDL-C) are associated with coronary heart disease events.There have been no intervention studies demonstrating that lowering LDL-C in the elderly will decrease coronary end points.However, some evidence does exist that pharmacological modification of triglycerides in the secondary prevention of coro- nary heart disease in an elderly population can decrease coronary events and overall mortality over a 5-year period.2Ideally, interventions in the elderly should provide a favorable benefit rapidly, otherwise, the benefit may not be seen during their remaining years.Hypertriglyceridemia induces a procoagulant state,3 and clotting factor abnormalities may be rapidly corrected with treatment of the hypertriglyceridemia.4 Thus, the treatment of hypertriglyceridemia may provide rapid benefit because of changes in clotting.The implications of this study are numerous.The National Cholesterol Education Program guidelines that primarily target LDL-C for therapeutic decisions and treatment goals may not be applicable to the elderly.Perhaps more emphasis should be placed on triglycerides and HDL-C and less on LDL-C in the elderly.Levels of triglycerides and HDL-C are frequently amenable to lifestyle changes such as weight loss and exercise, and these changes may be preferable to drugs in this population.When drugs are used, those favorably affecting triglycerides and HDL-C levels should be first choice.These comments are speculative, however, and most impor- tantly, we need well-designed intervention trials in the elderly.Until then, the management of dyslipidemia in the elderly will remain controversial and should be done on an individual basis.
No takes yet. Share an insight, caveat, or question.
MarkR. Goldstein (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: